It’s been a difficult year for many investors to digest. Despite higher interest rates, the economy looks strong, with employment figures continuing to remain robust. In fact, unemployment levels are near historic lows, suggesting the bear market that took place last year perhaps shouldn’t have happened. That said, there are clear reasons for investors to
0 Comments
Market conditions are not always the same. During bear markets, the objective of investors should be to preserve capital and ensure returns that beat inflation. However, when market sentiments are positive, the focus should be on maximizing returns. Of course, this does not imply that the portfolio should be entirely focused on growth stocks. However,
0 Comments
In 2014, Massachusetts-based T2 Biosystems (NASDAQ:TTOO) went public at $11 per share. Expectations were high for the young startup. Its sepsis-detecting products targeted a $20.3 billion industry, and T2’s Magnetic Resonance Platform (T2MR) was potentially game-changing. Shares would quickly rise to a pre-split $23. The product, however, would prove a dud. In 2020, most of
0 Comments
Investors should expect a steep selloff among artificial intelligence stocks, as Wall Street cashes in on the high valuations many companies in this sector provide. On the other hand, some high-potential AI names remain overlooked, and the recent AI craze has done little to uplift their valuation. Thus, as the rally cools, smart investors will
0 Comments
The biotech industry proved itself resilient in the face of the COVID-19 pandemic. With research from Mckinsey, venture capitalist (VC) companies increased investments from 2,200 in 2016 to 3,100 in 2021 in biotechnology (biotech) startups. These startups have advanced medicine overall, improving cell therapy, tissue regeneration, genetic medicine, and more. With increasing innovation, we see
0 Comments
In this article PENN AXON LYFT BMBL TWLO SMCI RIVN TTWO Follow your favorite stocksCREATE FREE ACCOUNT People walk by electric truck maker Rivian’s newly opened storefront in the Meatpacking District of Manhattan on June 23, 2023 in New York City. Spencer Platt | Getty Images Check out the companies making headlines after hours. Rivian
0 Comments
Last week, meme investors “discovered” Rite Aid (NYSE:RAD), sending its shares up 70%. The Wall Street Journal would quickly give the company a meme stock crown. For most traditional investors, Rite Aid looks like a terrible bet. The struggling drug retailer hasn’t been profitable since 2017, and a deal five years ago to sell 1,932
0 Comments
Artificial intelligence (AI) will have a profound impact on the medical industry, where it could help accelerate drug discovery and patient treatment, creating big opportunities for these top AI stocks to invest in. At the moment, new drug development has a ridiculous fail rate of 90%, according to the National Institutes of Health. Worse, according
0 Comments
With challenging economic circumstances forcing many households to adapt, shrewd investors just might benefit from stocks for paycheck-to-paycheck living. To be sure, the most recent data on inflation suggests that consumers should be feeling some relief. Nevertheless, a new LendingClub report notes that 61% of U.S. adults still live hand-to-mouth with their employers. Of course,
0 Comments
In this article PNC MTB BYND PLTR IFF Follow your favorite stocksCREATE FREE ACCOUNT Getty Images PNC Financial, Citizens Financial, M&T Bank — Regional bank stocks were broadly under pressure on Tuesday after Moody’s downgraded the credit in several smaller institutions. The ratings agency also said some larger banks were under review for a downgrade.
0 Comments